2022 Annual Report
Publication • 2023As we close another year of unprecedented challenges and achievements, I'm honored to share with you Treatment Action Group's (TAG) 2022 Annual Report.
European Commitments to TB R&D Investments: Promises Made to Be Broken?
Publication • 2022In this brief, TAG outlines the pathway the EU can take to scale up support for TB R&D, and advance the many European-sponsored TB vaccine candidates currently in the development pipeline.
2022 TAG Update
Publication • 2022As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.
Towards Pandemic Equity: Lessons from 30 Years of Syndemic Activism
TAGline • 2022By Mike Frick and Mark Harrington The articles in this 30th anniversary issue of TAGline grapple with “pandemic equity,” an increasingly common catchphrase in global health. COVID-19 has shown that “equity,” like its cousins “justice,” “fairness,” and “equality,” is one of those words whose use rises in proportion to its absence in practice. If it…
Community Representation in HIV Research: From Study Volunteers to Investigators
TAGline • 2022By Cheriko A. Boone, Abraham Johnson, and Richard Jefferys In a 1989 article by Dr. Anthony Fauci, “AIDS — Challenges to Basic and Clinical Biomedical Research” — which preceded Treatment Action Group’s founding by just a few years — he described NIH/NIAID’s work on establishing the Community Programs for Clinical Research on AIDS, and he…
Risk of Breakthrough COVID-19 Infections and Disease in Vaccinated People with HIV
Publication • 2022This fact sheet on breakthrough COVID-19 infections among people living with HIV was co-produced by TAG and our partners the Black AIDS Institute, Southern AIDS Coalition and the COVID-19 Prevention Network.
Introducing 1/4/6×24: A Campaign That Draws Inspiration from the Past to Change the Trajectory of the Future Fight to End Tuberculosis
TAGline • 2022By Lindsay McKenna, Mike Frick, and Mark Harrington At the 24th International AIDS Conference in Montreal this summer, TAG, Partners In Health (PIH), and Médecins Sans Frontières (MSF) launched the 1/4/6×24 Campaign to accelerate equitable global uptake of newly discovered safer, shorter regimens to cure all forms of tuberculosis (TB). The “1,” “4,” and “6”…
Breaking Barriers: Surveying Community Perspectives of COVID-19 Vaccine Research
Publication • 2021This report aims to raise the profile of discussions that have been taking place regarding community understanding and involvement in COVID-19 vaccine research. It presents the results of an online survey developed by TAG, along with the Black AIDS Institute and the COVID-19 Prevention Trials Network in the fall of 2020 seeking community perspectives on COVID-19 vaccine development.
Update on HIV Vaccine Research
Publication • 2021Developing an HIV vaccine is a difficult scientific challenge, but remains a critical priority. This handout provides an update on HIV vaccine research and a summary of results from the efficacy trials that have been conducted to date, and it was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern…
TAG and COVID-19 Prevention Network Fact Sheets
Publication • 2021These three fact sheets were developed by TAG in partnership with the COVID-19 Prevention Network (CoVPN) and the Black AIDS Institute (BAI), and they aim to foster community understanding of COVID-19 vaccine research and development, as well as highlight community perspectives on the topic.